Bolag Altan Selected Research

HSP110 Heat-Shock Proteins

11/2017	Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis.
4/2016	Nuclear heat shock protein 110 expression is associated with poor prognosis and chemotherapy resistance in gastric cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bolag Altan Research Topics

Disease

22	Neoplasms (Cancer) 02/2019 - 01/2014
4	Stomach Neoplasms (Stomach Cancer) 11/2017 - 04/2016
4	Cholangiocarcinoma 06/2017 - 11/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 04/2015
3	Lymphatic Metastasis 01/2018 - 07/2017
3	Adenocarcinoma 01/2018 - 09/2017
3	Neoplasm Metastasis (Metastasis) 11/2017 - 11/2013
3	Breast Neoplasms (Breast Cancer) 11/2017 - 07/2017
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 02/2017
2	Adenocarcinoma of Lung 10/2017 - 08/2015
1	Thymoma (Thymic Carcinoma) 02/2019
1	Lung Neoplasms (Lung Cancer) 03/2018
1	Circulating Neoplastic Cells 03/2018
1	Prostatic Neoplasms (Prostate Cancer) 07/2017
1	Colonic Neoplasms (Colon Cancer) 07/2017
1	Esophageal Squamous Cell Carcinoma 04/2017
1	Neoplasms, Cystic, Mucinous, and Serous 03/2017
1	Nijmegen Breakage Syndrome 10/2016
1	Gallbladder Neoplasms (Gallbladder Cancer) 09/2016
1	Hyperplasia 09/2016
1	Carcinogenesis 09/2016
1	Pancreaticobiliary Maljunction 09/2016
1	Fever (Fevers) 04/2016
1	Hypoxia (Hypoxemia) 12/2015
1	Colorectal Neoplasms (Colorectal Cancer) 03/2015
1	Infections 01/2014

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 09/2017 - 10/2016
4	StathminIBA 10/2017 - 09/2016
3	PhosphoproteinsIBA 10/2017 - 06/2014
2	NivolumabIBA 03/2018 - 01/2018
2	Gemcitabine FDA Link 12/2017 - 06/2017
2	HSP110 Heat-Shock ProteinsIBA 11/2017 - 04/2016
2	ErbB Receptors (EGF Receptor)IBA 09/2017 - 03/2015
2	Cadherins (E-Cadherin)IBA 09/2017 - 02/2017
2	Pharmaceutical PreparationsIBA 04/2017 - 04/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 04/2017 - 08/2015
2	Small Interfering RNA (siRNA)IBA 02/2017 - 12/2015
1	Carbonic Anhydrase IXIBA 02/2019
1	Immune Checkpoint InhibitorsIBA 03/2018
1	Carcinoembryonic AntigenIBA 03/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2018
1	AntibodiesIBA 01/2018
1	Large Neutral Amino Acid-Transporter 1IBA 01/2018
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 12/2017
1	ClaudinsIBA 11/2017
1	Androgen Receptors (Androgen Receptor)IBA 11/2017
1	AgarIBA 11/2017
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 09/2017
1	Carrier Proteins (Binding Protein)IBA 09/2017
1	Endoplasmic Reticulum Chaperone BiPIBA 09/2017
1	Glucose (Dextrose)FDA LinkGeneric 09/2017
1	Molecular Chaperones (Chaperone, Molecular)IBA 09/2017
1	Aldehyde Dehydrogenase 1 FamilyIBA 09/2017
1	VimentinIBA 09/2017
1	Phenobarbital (Luminal)FDA Link 09/2017
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2017
1	Epithelial Cell Adhesion MoleculeIBA 09/2017
1	Estrogen ReceptorsIBA 09/2017
1	human ERBB2 proteinIBA 09/2017
1	NucleobindinsIBA 07/2017
1	Indicators and Reagents (Reagents)IBA 06/2017
1	Oncogene Proteins (Oncogene Protein)IBA 05/2017
1	Docetaxel (Taxotere)FDA Link 04/2017
1	Antineoplastic Agents (Antineoplastics)IBA 04/2017
1	F-Box ProteinsIBA 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2016
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 10/2016
1	phytobacteriomycin (PBM)IBA 09/2016
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 07/2016
1	Cisplatin (Platino)FDA LinkGeneric 04/2016
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 04/2016
1	Fluorouracil (Carac)FDA LinkGeneric 04/2016
1	LigandsIBA 02/2016
1	NK Cell Lectin-Like Receptor Subfamily KIBA 02/2016
1	Transcription Factors (Transcription Factor)IBA 12/2015
1	NAD (NADH)IBA 08/2015
1	NF-kappa B (NF-kB)IBA 08/2015
1	Beclin-1IBA 08/2015
1	src-Family KinasesIBA 04/2015
1	Cetuximab (Erbitux)FDA Link 03/2015
1	Histone Deacetylase InhibitorsIBA 01/2014
1	entinostat (MS 275)IBA 01/2014
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2014
1	Blood Group Antigens (Blood Groups)IBA 01/2014
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2013

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2018 - 08/2015
3	Therapeutics 04/2017 - 02/2017
1	Gastrectomy 11/2017
1	Neoadjuvant Therapy 04/2017
1	Adjuvant Chemotherapy 04/2016